Advances in brain barriers and brain fluids research in 2021: great progress in a time of adversity-Reference-Cited by-同舟云学术

Advances in brain barriers and brain fluids research in 2021: great progress in a time of adversity

Published:2022-06-09 Issue:1 Volume:19 Page:
ISSN:2045-8118
Container-title:Fluids and Barriers of the CNS
language:en
Short-container-title:Fluids Barriers CNS

Author:

Keep Richard F.,Jones Hazel C.,Drewes Lester R.

Abstract

AbstractThis editorial highlights advances in brain barrier and brain fluid research in 2021. It covers research on components of the blood–brain barrier, neurovascular unit and brain fluid systems; how brain barriers and brain fluid systems are impacted by neurological disorders and their role in disease progression; and advances in strategies for treating such disorders.

Publisher

Springer Science and Business Media LLC

Subject

Cellular and Molecular Neuroscience,Developmental Neuroscience,Neurology,General Medicine

Link

https://link.springer.com/content/pdf/10.1186/s12987-022-00343-x.pdf

Reference154 articles.

1. Castro Dias M, Odriozola Quesada A, Soldati S, Bosch F, Gruber I, Hildbrand T, Sonmez D, Khire T, Witz G, McGrath JL, et al. Brain endothelial tricellular junctions as novel sites for T cell diapedesis across the blood–brain barrier. J Cell Sci. 2021;134(8):15.

2. Winkler L, Blasig R, Breitkreuz-Korff O, Berndt P, Dithmer S, Helms HC, Puchkov D, Devraj K, Kaya M, Qin Z, et al. Tight junctions in the blood–brain barrier promote edema formation and infarct size in stroke—ambivalent effects of sealing proteins. J Cereb Blood Flow Metab. 2021;41(1):132–45.

3. Anquetil T, Solinhac R, Jaffre A, Chicanne G, Viaud J, Darcourt J, Orset C, Geuss E, Kleinschnitz C, Vanhaesebroeck B, et al. PI3KC2beta inactivation stabilizes VE-cadherin junctions and preserves vascular integrity. EMBO Rep. 2021;22(6): e51299.

4. Gong S, Cao G, Li F, Chen Z, Pan X, Ma H, Zhang Y, Yu B, Kou J. Endothelial conditional knockdown of NMMHC IIA (nonmuscle myosin heavy chain IIA) attenuates blood–brain barrier damage during ischemia–reperfusion injury. Stroke. 2021;52(3):1053–64.

5. Wu L, Islam MR, Lee J, Takase H, Guo S, Andrews AM, Buzhdygan TP, Mathew J, Li W, Arai K, et al. ErbB3 is a critical regulator of cytoskeletal dynamics in brain microvascular endothelial cells: implications for vascular remodeling and blood brain barrier modulation. J Cereb Blood Flow Metab. 2021;41(9):2242–55.